Gilbert S. Omenn Fellowship
Ellen Eaton, MD, MSPH
2017-2019 Omenn Fellow
James Burke, MD, MS
2015-2017 Omenn Fellow
Deidra Crews, MD, ScM, FASN
2013-2015 Omenn Fellow
The National Academies of Sciences, Engineering, and Medicine (the National Academies) bring together the most eminent researchers, policy experts, and clinicians from across the country to work together to provide nonpartisan, scientific, and evidence-based advice to national, state, and local policymakers; academic leaders; health care administrators; and the public. The National Academies are uniquely qualified to offer an exceptional learning environment to selected early-career health science scholars and future leaders in medicine and public health. Through an endowment from Gilbert S. Omenn, M.D., Ph.D., and Martha Darling, the Gilbert S. Omenn Fellowship was established under the National Academy of Medicine (NAM) Fellowship program in 2012. The award is named for Dr. Omenn, a professor of medicine, genetics, and public health and founder of the Center for Computational Medicine and Bioinformatics at the University of Michigan Medical School. He is a physician-scientist whose career bridges biomedical research, public health and public policy, and this fellowship will reflect the integrative role that is emblematic of his professional achievements. More information on Dr. Omenn can be found at: www.ccmb.med.umich.edu/omenn.
The overall purpose of the Gilbert S. Omenn Fellowship is to enable talented, early-career scholars combining biomedical science and population health to participate actively in health- and medicine-related study process of the National Academies, promoting the integration of public health and medicine–both scientifically and through practice and policy. The Omenn Fellowship aims to foster a cadre of physician-scientists who will integrate biomedical research, population health, and health policy and will expand the nation’s capacity for research, leadership, and policy development that advances health. The program especially welcomes nominations of under-represented minority candidates.
The Omenn Fellowship is awarded for a two-year period. During this time, the fellow is expected to continue to work at his/her main academic post, while being assigned to a health- and medicine-related board of the National Academies. The boards are:
- Children, Youth, and Families
- Food and Nutrition
- Global Health
- Health Care Services
- Health Sciences Policy
- Population Health and Public Health Practice
The fellowship requires a 10 to 20 percent commitment of time over two years and includes attendance at a one-week orientation to health policy in October, the Fall NAM Annual Meeting, and meetings of an assigned board. Additionally, the fellow will participate actively in the work of an appropriate expert study committee or roundtable, including contributing to its reports or other products. Studies will be identified that would enable the fellow to contribute to the value of integrating medicine and public health.
This experience will introduce the Omenn Fellow to a variety of experts and perspectives, including legislators, government officials, industry leaders, executives of voluntary health organizations, scientists, and other health professionals. In addition, each fellow will be assigned a NAM member who will serve as a senior mentor during the two years of the fellowship.
A flexible research stipend of $25,000 is awarded to each Omenn Fellow. The stipend will be administered through the appropriate department in the fellow’s home institution. Stipends are not intended for use as salary offsets.
Nominees for the Omenn Fellowship must meet the following requirements:
- Nomination by a member of the NAM
- An M.D. or D.O. with additional study in the medical sciences, public health, and/or public policy
- One-to-five years out from completion of residency and fellowship training or receiving the terminal doctoral degree, in an appropriate faculty position or its equivalent
- Able to commit 10 to 20 percent of time to the fellowship for two years, including all the specified experiences
- Endorsement by the department chair, institute director, or equivalent
- U.S. citizenship or permanent resident status at the time of the nomination
Nominees will be evaluated by a NAM-appointed committee according to:
- Professional accomplishments including research and publications
- Potential for leadership in bridging biomedical research, population health, and health policy
- Quality of letters of recommendation
- Expertise in an area of relevance to the NAM
A complete nomination packet must be submitted electronically through the online nomination system at https://fellowship.nam.edu/ and will include the following documents:
- A nomination letter from a member of the NAM
- Three (3) letters of reference
- A supporting letter from the candidate’s department chair, institute director, or equivalent
- An up-to-date curriculum vitae
- A brief one-page bio
Fellowships will be awarded in odd years.
- March 1 | Call for nominations
- June 1 | Nomination packets due
- Mid-July | Awardee notified
- October | Fellow Orientation Week at the NAM & Introduction to NAM membership at the NAM Annual Meeting
Inquiries about the Omenn Fellowship should be directed to:
Gregg S. Margolis, PhD
Health Policy Fellowships and Leadership Programs
National Academy of Medicine
500 Fifth Street, NW
Washington, DC 20001
Phone: (202) 334-1506
Current Omenn Fellow Biography
Ellen Eaton, MD, MSPH
Dr. Ellen F. Eaton is an Assistant Professor of Infectious Diseases in the Department of Medicine at the University of Alabama, Birmingham (UAB). She is currently a K12 Scholar in the Center for Outcomes and Effectiveness Research and Education, Minority Health Research Center. Dr. Eaton completed her Internal Medicine Residency and Chief Residency at Stanford University Hospital and Clinics and her Infectious Diseases fellowship and Masters of Science in Public Health (MSPH) degree in Health Care Organization and Policy at UAB. Dr. Eaton’s research focuses on translating emerging HIV treatment and prevention options into real world, patient-centered clinical practice to improve health outcomes for those both at risk for and living with HIV.